Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 23,200 shares, a growth of 107.1% from the March 31st total of 11,200 shares. Based on an average trading volume of 204,200 shares, the short-interest ratio is presently 0.1 days.
Shares of Fresenius SE & Co. KGaA stock opened at $9.04 on Friday. The company has a current ratio of 1.13, a quick ratio of 0.85 and a debt-to-equity ratio of 0.64. The business has a 50-day moving average price of $8.95 and a two-hundred day moving average price of $9.98. Fresenius SE & Co. KGaA has a 1-year low of $7.37 and a 1-year high of $14.81. The company has a market cap of $20.19 billion, a P/E ratio of 9.32 and a beta of 1.31.
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) last issued its quarterly earnings results on Tuesday, February 22nd. The company reported $0.27 earnings per share for the quarter. Fresenius SE & Co. KGaA had a return on equity of 6.73% and a net margin of 4.85%. The firm had revenue of $11.40 billion during the quarter. Equities research analysts forecast that Fresenius SE & Co. KGaA will post 0.96 EPS for the current fiscal year.
Fresenius SE & Co. KGaA Company Profile (Get Rating)
Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
- Get a free copy of the StockNews.com research report on Fresenius SE & Co. KGaA (FSNUY)
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
- O’Reilly Automotive Hits A Pothole
- There’s An Institutional Floor In Keurig Dr. Pepper
- Ford Falls Despite Optimistic Outlook
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.